AACR Stories
Research-driven advances in liquid biopsy are beginning to show how these less invasive tests can be used for early cancer detection, treatment selection, and patient monitoring.
Learn More in AACR Stories
Research-driven advances in liquid biopsy are beginning to show how these less invasive tests can be used for early cancer detection, treatment selection, and patient monitoring.
Learn More in AACR StoriesCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreScreening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the ReportMore than 315,000 people in the United States are expected to be diagnosed with breast cancer this year. Read about prevention, screening, and treatment options for breast cancer.
Learn MoreResearchers Showcase How AACR Project GENIE Is Powering New Insights into Cancer Care
Read the AACR BlogThe report highlights the AACR’s impact on the cancer community during the past year while advancing our mission to prevent and cure all cancers.
Read the ReportWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2025. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
